PDE5A and diabetes mellitus: Moreover, according to a clinic trial in human and murine models of diabetes, treatment with a PDE5 inhibitor sildenafil induced increment of SIRT1 through a downregulation of the miR-22 expression, resulting in ameliorating visceral adipose tissue [44].